Abstracts

BLOOD MICROBIOTA CORRELATES WITH INFLAMMATION AND ART-MEDIATED IMMUNE RESTORATION

HIV infection impairs the mucosal immunity and leads to bacterial translocation, fueling chronic inflammation and disease progression. The compositional profile of the translocated bacteria remains undefined. A total of 80 samples from 50 individuals were studied: 30 HIV-infected individuals with <350 CD4+ T-cells/uL or AIDS at diagnosis and after 48 weeks of first-line ART, and…

HPV CLEARANCE AND REINFECTION IN 2 YEARS AFTER RANDOMIZATION TO CRYOTHERAPY OR LEEP

Women with HIV are at increased risk of high-risk human papillomavirus (hrHPV) infection. We compared hrHPV clearance and reinfection in HIV-infected women randomized to cryotherapy or loop electrosurgical excisional procedure (LEEP) for treatment of cervical intraepithelial neoplasia grade 2 or 3 (CIN2/3). From June 2011 to July 2014, HIV-infected women enrolled at the Coptic Hope…

HPV DNA TESTS FOR CERVICAL CANCER SCREENING OF HIV-INFECTED WOMEN

HPV DNA testing has excellent sensitivity but poor specificity for cervical cancer screening among HIV-infected women. We evaluated whether the point-of-care test, Xpert™ HPV, could be adapted to improve performance characteristics for screening HIV-infected women. A clinical study of 586 HIV-uninfected and 535 HIV-infected women, aged 30-65 years, was conducted in Cape Town, South Africa.…

RELATION OF CIN2 PROGRESSION WITH SERIAL CERVICOVAGINAL CYTOKINE/CHEMOKINE LEVELS

Women living with HIV are high-risk for cervical intraepithelial neoplasia-2 (CIN2), a potentially pre-cancerous diagnosis. We characterized longitudinal variations in cervicovaginal lavage (CVL) chemokine/cytokine levels and their temporal relation with CIN2 and its progression. N=104 HIV-positive women (age < 46) were selected from the Women’s Interagency HIV Study (WIHS). To avoid misclassification, we excluded women…

HPV GENOTYPING IN 1,088 ANAL HSIL CASES: EXPECTED AND UNEXPECTED RESULTS

High-grade squamous intraepithelial lesions (HSIL), the anal cancer precursors, are caused by high-risk human papillomavirus (hrHPV). HrHPV-negative HSILs occur occasionally in clinical practice and constitute an unexpected departure from that rule leading to diagnostic and therapeutic challenges. Using 1,088 simultaneously collected anal swab and histologic HSIL specimens, we aimed to determine the distribution of hrHPV…

PRIMARY HPV SCREENING IN WOMEN LIVING WITH HIV

Primary HPV Screening (PHS) utilizes an oncogenic human papillomavirus (oncHPV) assay as the initial cervical cancer screening test (instead of a Pap test). Recent US guidelines support PHS in women in the general population (30-65 years of age), and suggest oncHPV- women should be retested in 5 years. For oncHPV+ women, reflex HPV genotyping is…